Yousif Capital Management LLC Sells 1,279 Shares of Tenet Healthcare Co. (NYSE:THC)

Yousif Capital Management LLC cut its holdings in shares of Tenet Healthcare Co. (NYSE:THC) by 4.1% in the 4th quarter, Holdings Channel reports. The firm owned 29,914 shares of the company’s stock after selling 1,279 shares during the period. Yousif Capital Management LLC’s holdings in Tenet Healthcare were worth $3,776,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Plato Investment Management Ltd acquired a new stake in Tenet Healthcare in the third quarter valued at about $28,000. ORG Wealth Partners LLC bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at approximately $30,000. Financial Management Professionals Inc. lifted its stake in Tenet Healthcare by 2,222.2% in the 3rd quarter. Financial Management Professionals Inc. now owns 209 shares of the company’s stock valued at $35,000 after purchasing an additional 200 shares during the last quarter. True Wealth Design LLC bought a new stake in shares of Tenet Healthcare during the third quarter worth $38,000. Finally, Spire Wealth Management lifted its stake in shares of Tenet Healthcare by 19.5% in the 4th quarter. Spire Wealth Management now owns 558 shares of the company’s stock valued at $70,000 after acquiring an additional 91 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

THC has been the subject of several research reports. The Goldman Sachs Group downgraded Tenet Healthcare from a “buy” rating to a “neutral” rating and dropped their target price for the company from $196.00 to $140.00 in a research report on Monday, December 16th. Raymond James lowered shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 target price on the stock. in a report on Friday, November 22nd. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. Barclays raised their target price on Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 8th. Finally, Truist Financial decreased their price target on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $165.00.

Tenet Healthcare Trading Up 0.6 %

THC opened at $140.63 on Friday. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. The company has a fifty day moving average price of $133.96 and a two-hundred day moving average price of $148.59. The company has a market cap of $13.37 billion, a P/E ratio of 4.51, a price-to-earnings-growth ratio of 0.63 and a beta of 2.05. Tenet Healthcare Co. has a 1-year low of $86.70 and a 1-year high of $171.20.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.